Company news

Heron Therapeutics, Inc. news in 2026

Heron Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026

October 26, 2026

Heron Therapeutics Announces Second Quarter 2026 Financial Results

August 10, 2026

Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026

July 27, 2026

U.S. District Court Issues Decision Regarding CINVANTI® Patents

June 1, 2026

Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

May 11, 2026

Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026

April 27, 2026

Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results

February 25, 2026

Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026

February 17, 2026

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth

January 9, 2026

Calls in 2026

Decks in 2026